CNMD实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 04:00):

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide...

Stats
今日成交量	546 382
平均成交量	557 580
市值	2.16B
EPS	$1.060 ( 2024-04-24 )
下一个收益日期	( $0.920 ) 2024-07-24
Last Dividend	$0.200 ( 2023-12-15 )
Next Dividend	$0 ( N/A )
P/E	26.87
ATR14	$0.0970 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Beyer Pat	Buy	3 000	Common Stock
2024-04-24	Beyer Pat	Buy	20 060	Options To Purchase Common Stock
2024-03-28	Garner Todd W	Buy	227	Common Stock
2024-03-28	Cohen Heather L	Buy	227	Common Stock
2024-03-08	Cohen Heather L	Buy	25 000	Common Stock

INSIDER POWER
43.14
Last 96 transactions
Buy: 441 997 \| Sell: 209 124

音量相关性

長: 0.53 (weak)

短: -0.33 (neutral)

Signal:(47.277) Neutral

Conmed Corp 相关性

10 最正相关
AGI	0.902
CCEP	0.902
COO	0.9
DRD	0.9
DECK	0.887
WPM	0.886
PKX	0.881
EUDG	0.88
NVO	0.877
NGG	0.873

10 最负相关
ENIA	-0.843
DBMF	-0.841
RKLY	-0.836
LXU	-0.832
KMLM	-0.828
NIC	-0.826
GDXD	-0.821
NXQ	-0.817
DGZ	-0.817
DUST	-0.816

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Conmed Corp 相关性 - 货币/商品

-0.19
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.35
( neutral )

0.57
( weak )

0.13
( neutral )

Conmed Corp 财务报表

Annual	2023
营收:	$1.24B
毛利润:	$643.07M (51.82 %)
EPS:	$2.10

FY	2023
营收:	$1.24B
毛利润:	$643.07M (51.82 %)
EPS:	$2.10

FY	2022
营收:	$1.05B
毛利润:	$571.25M (54.64 %)
EPS:	$-2.68

FY	2021
营收:	$1.01B
毛利润:	$568.04M (56.21 %)
EPS:	$2.14

Financial Reports:

No articles found.

Conmed Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Conmed Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.56 - Increase likely (51.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-03-13
Last Dividend	$0.200	2023-12-15
Next Dividend	$0	N/A
Payout Date	2024-01-05
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$9.25	--
Avg. Dividend % Per Year	0.49%	--
Score	4.91	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.56
Div. Directional Score	9.10	--

Next Divdend (Est)
(2024-07-01)

$0.203 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

4.91

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.600	2.31%
2013	$0.650	2.32%
2014	$0.800	1.87%
2015	$0.800	1.78%
2016	$0.800	1.88%
2017	$0.800	1.81%
2018	$0.800	1.58%
2019	$0.800	1.26%
2020	$0.800	0.72%
2021	$0.800	0.72%
2022	$0.800	0.55%
2023	$0.800	0.89%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0653	1.500	8.69	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0357	1.200	8.81	10.00	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0.298	-1.000	7.02	-7.02	[0 - 1]
currentRatioTTM	2.18	0.800	4.09	3.27	[1 - 3]
quickRatioTTM	0.945	0.800	9.15	7.32	[0.8 - 2.5]
cashRatioTTM	0.116	1.500	-0.466	-0.699	[0.2 - 2]
debtRatioTTM	0.429	-1.500	2.85	-4.27	[0 - 0.6]
interestCoverageTTM	3.66	1.000	9.76	9.76	[3 - 30]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.60	2.00	7.70	10.00	[0 - 20]
debtEquityRatioTTM	1.159	-1.500	5.36	-8.04	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.113	1.000	9.73	9.73	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.160	1.000	-0.223	-0.223	[0.2 - 2]
assetTurnoverTTM	0.546	0.800	9.69	7.75	[0.5 - 2]
Total Score				10.65

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.54	1.000	7.52	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.60	2.00	8.47	10.00	[0 - 30]
dividendYielPercentageTTM	1.171	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	0.298	1.500	7.02	-7.02	[0 - 1]
pegRatioTTM	1.133	1.500	5.78	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.126	1.000	9.36	0	[0.1 - 0.5]
Total Score				7.56

Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.